Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 October 2006

Low-dose oral contraceptive to re-induce menstrual bleeding in amenorrheic women on DMPA treatment: A randomized clinical trial

Homayon Sadeghi-Bazargani, Farnaz Ehdaeivand, Shahnam Arshi, Hasan Eftekhar, Hashem Sezavar, Louiz Amanati

Med Sci Monit 2006; 12(10): CR420-425 :: ID: 459196

Abstract

Background: Depot medroxyprogesterone acetate (DMPA), a long-acting contraceptive, has many advantages
over other hormonal contraceptives. However, its major discontinuance reason is bleeding disorders.
Our aim was to study bleeding complications of DMPA when used as a contraceptive in the Ardabil district and a clinical trial of low-dose oral contraceptive (LD-OC) pills in controlling these complications.
Material/Methods: All 917 women referred to Ardabil’s health centers to have a DMPA injection for the fi rst time were entered into a longitudinal study. Those complaining of menstrual cessation were entered into a double-blinded randomized clinical trial. Data were collected by means of nine questionnaires, seven
of which were used for descriptive purposes and two for clinical trial study. The data were analyzed
with the SPSS statistical package.
Results: Those DMPA users with a cesarean section history had a higher chance of bleeding complications.
Four hundred forty-four of the 917 women receiving the injection discontinued using it before the
end of the study period. The main reason for discontinuation (in 70%) was irregular menstrual
bleedings and menstrual cessation. In the clinical trial of women with bleeding cessation, 70% of
those receiving the LD-OC pill experienced menstrual bleedings again, compared with only 22.7%
in the placebo group. The discontinuation rate in the drug group was lower than in the placebo
group as well (,i>p

Keywords: Amenorrhea - drug therapy, Contraceptives, Oral - adverse effects, Dose-Response Relationship, Drug, Medroxyprogesterone Acetate - adverse effects, Menstruation - drug effects, Patient Compliance

Add Comment 0 Comments

Editorial

01 April 2025 : Editorial  

Editorial: Rapid Testing for the Avian Influenza A(H5N1) Virus is Urgently Required as Infections in Poultry and Dairy Cows are on the Rise, and so is Transmission to Humans

Dinah V. Parums

DOI: 10.12659/MSM.949109

Med Sci Monit 2025; 31:e949109

0:00

In Press

Clinical Research  

Longitudinal Evaluation of Metabolic Benefits of Inactivated COVID-19 Vaccination in Diabetic Patients in T...

Med Sci Monit In Press; DOI: 10.12659/MSM.947450  

0:00

Clinical Research  

Impact of Voltage Level on Hospitalization and Mortality in Electrical Injury Cases: A Retrospective Analys...

Med Sci Monit In Press; DOI: 10.12659/MSM.947675  

Clinical Research  

Comparative Study of Plantar Load and Foot Posture Characteristics in Male Elite Squash Players and Non-Ath...

Med Sci Monit In Press; DOI: 10.12659/MSM.947828  

Clinical Research  

Dental Students’ Opinions on Use of Artificial Intelligence: A Survey Study

Med Sci Monit In Press; DOI: 10.12659/MSM.947658  

Most Viewed Current Articles

17 Jan 2024 : Review article   8,071,874

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   702,992

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   30,169

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   24,060

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750